Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice

Published:2021-03-20 Issue:3 Volume:8 Page:1933-1943
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Pieronne‐Deperrois Marie¹^ORCID,Guéret Alexandre¹,Djerada Zoubir²,Crochemore Clément³,Harouki Najah¹,Henry Jean‐Paul¹,Dumesnil Anaïs¹,Larchevêque Marine¹,Rego Jean‐Claude⁴,Rego Jean‐Luc⁴,Nicol Lionel¹,Richard Vincent¹,Jaisser Frédéric⁵,Kolkhof Peter⁶,Mulder Paul¹,Monteil Christelle³,Ouvrard‐Pascaud Antoine¹

Affiliation:

1. Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University Rouen France

2. Pharmacology Department Reims University Hospital Reims France

3. EA4651 Toxemac‐ABTE, Rouen Medical School, UNIROUEN, Normandy University Rouen France

4. SCAC Behavioral Analysis Platform, Rouen Medical School, UNIROUEN, Normandy University Rouen France

5. Inserm U1138, Cordeliers Institute, Paris‐VI University Paris France

6. Bayer AG Wuppertal Germany

Funder

Bayer

Institut de France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13219

Reference47 articles.

1. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

2. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

3. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

4. Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

5. Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression analysis to identify mechanisms underlying improvement of myocardial fibrosis by finerenone in SHR;Biochemical Pharmacology;2024-02

2. The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances;Clinical and Experimental Nephrology;2023-10-17

3. Mineralocorticoid receptor antagonists in cardiovascular translational biology;Cardiovascular Endocrinology & Metabolism;2023-08-21

4. The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction;Cardiovascular Diabetology;2023-06-29

5. Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2023-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3